Resalis Therapeutics’ Post

Resalis’ CSO, Riccardo Panella, will attend the 20th Annual Meeting of the Oligonucleotide Therapeutics Society from October 6-9 in Montreal. This global event brings together scientists, researchers, and industry leaders dedicated to advancing oligonucleotide therapeutics. Riccardo will participate in presentations, panel discussions, poster sessions, and networking opportunities, engaging with experts in this rapidly evolving field focused on using short DNA or RNA molecules to regulate gene expression. #OTS2024 #OTS24 #OligoMeeting

  • graphical user interface, application, PowerPoint

To view or add a comment, sign in

Explore topics